PPARα agonist fenofibrate attenuates TNF-α-induced CD40 expression in 3T3-L1 adipocytes via the SIRT1-dependent signaling pathway (Q42820928)

8 November 2017

PPARα agonist fenofibrate attenuates TNF-α-induced CD40 expression in 3T3-L1 adipocytes via the SIRT1-dependent signaling pathway (English)

1 reference

8 November 2017

1 reference

Weirong Wang

1

1 reference

8 November 2017

Qinqin Lin

2

1 reference

8 November 2017

Rong Lin

3

1 reference

8 November 2017

Jiye Zhang

4

1 reference

8 November 2017

Feng Ren

5

1 reference

8 November 2017

Jianfeng Zhang

6

1 reference

8 November 2017

Meixi Ji

7

1 reference

8 November 2017

Yanxiang Li

8

1 reference

8 November 2017

language of work or name

English

0 references

publication date

17 April 2013

1 reference

Experimental Cell Research

8 November 2017

1 reference

8 November 2017

319

1 reference

8 November 2017

1523-1533

1 reference

8 November 2017

10

1 reference

The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity

8 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

Anti-inflammatory effect of resveratrol on adipokine expression and secretion in human adipose tissue explants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

The inflammatory receptor CD40 is expressed on human adipocytes: contribution to crosstalk between lymphocytes and adipocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

SIRT1 regulates TNF-α-induced expression of CD40 in 3T3-L1 adipocytes via NF-κB pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

Emerging roles of PPARs in inflammation and immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

The peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 prevents TNF-α-induced NF-κB activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

Sirt1 acts in association with PPAR to protect the heart from hypertrophy, metabolic dysregulation, and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

Reduction of atherosclerosis by the peroxisome proliferator-activated receptor alpha agonist fenofibrate in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

Effects of short-term fenofibrate treatment on circulating markers of inflammation and hemostasis in patients with impaired glucose tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

SIRT1 longevity factor suppresses NF-κB -driven immune responses: regulation of aging via NF-κB acetylation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

Fenofibrate attenuates tubulointerstitial fibrosis and inflammation through suppression of nuclear factor-κB and transforming growth factor-β1/Smad3 in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

Fenofibrate suppresses microvascular inflammation and apoptosis through adenosine monophosphate-activated protein kinase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

High glucose and glucosamine induce insulin resistance via different mechanisms in 3T3-L1 adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

Protective effects of paeoniflorin against cobalt chloride-induced apoptosis of endothelial cells via HIF-1α pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

C-reactive protein-induced expression of CD40-CD40L and the effect of lovastatin and fenofibrate on it in human vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

SirT1 regulates adipose tissue inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

Differential effects of polyphenols and alcohol of red wine on the expression of adhesion molecules and inflammatory cytokines related to atherosclerosis: a randomized clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

Effect of resveratrol on platelet activation in hypercholesterolemic rats: CD40-CD40L system as a potential target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

The role of Sp1 and NF-kappa B in regulating CD40 gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

NF-kappaB: a key role in inflammatory diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

Resveratrol inhibits interleukin 1β-mediated inducible nitric oxide synthase expression in articular chondrocytes by activating SIRT1 and thereby suppressing nuclear factor-κB activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

AMPK inhibits fatty acid-induced increases in NF-kappaB transactivation in cultured human umbilical vein endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

Activation of AMPK inhibits inflammation in MRL/lpr mouse mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

Berberine suppresses proinflammatory responses through AMPK activation in macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

Macrophage alpha1 AMP-activated protein kinase (alpha1AMPK) antagonizes fatty acid-induced inflammation through SIRT1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

PPARalpha activators upregulate eNOS activity and inhibit cytokine-induced NF-kappaB activation through AMP-activated protein kinase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

Resveratrol activates AMPK and suppresses LPS-induced NF-κB-dependent COX-2 activation in RAW 264.7 macrophage cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.04.007

10.1016/J.YEXCR.2013.04.007

7 January 2021

Identifiers

DOI

1 reference

8 November 2017

1 reference